
neolexon Aphasia offers digital speech therapy for patients with aphasia and/or apraxia of speech who have language impairments due to a neurological condition. The digital application aims to specifically intensify speech therapy and improve linguistic abilities. Neolexon Aphasia is only applicable as a supplement to treatment with a speech therapist. The application is not intended to provide information for diagnostic or therapeutic decisions. Indications: Dysphasia and aphasia (R47.0), Apraxia (R48.2).
Pricing
Paid
Manufacturer price €223.01 per prescription (90 days). DiGA directory: https://diga.bfarm.de/en/verzeichnis/01196
Category
Digital Therapeutics
Tags
—
Added
Sep 2026
Conditions (ICD-10)
Categories
Pros
- Permanently listed in the German BfArM DiGA directory
- Prescribable and reimbursed by German statutory health insurance
- Therapeutic area: Other